Sunday, January 6, 2019

Drug Companies Admit That Curing Patients Is Bad For Business

Some of you may may have read this article written by Goldman Sachs analyst Salveen Richter earlier last year, but not me. I only read the article recently while looking for interesting articles so I can post on this blog.

My nephew had a anaphylactic shock (after being given the wrong food at their resort) while on holiday in Bali recently. Fortunately they used both the Epipens they had on him and he was discharged from hospital shortly after observation.

Because they couldn't find any Epipens anywhere in the whole of Bali, my wife ordered two for them in Singapore and then my mother-in-law flew there to make sure they had spare Epipens for the rest of their holiday.

Other than pricing their Epipens ridiculously expensive to make money, big drug companies have admitted that developing one-off treatments don't make them much money. They prefer to make pills/ drugs that just manages but do not totally cure diseases so that they are able to make more money.

Reliance on the medication (to keep the condition at bay) will ensure continuous streams of income.

Back in 2014, Bayer's CEO openly admitted that they developed medication for rich Westerners and not for the poor. Rather than wanting to save lives, they are more interested in maximising profits.

As we wrote before, we don't aim to be the biggest private physiotherapy chain of clinics in Singapore. We at Physio Solutions and Sports Solutions just want to be the best at treating the cause of your pain quickly. If we can get you better in 2-3 sessions, we won't want you to come back for further for more sessions unnecessarily. That's our promise to you.

No comments:

Post a Comment